Skip to main content

Latest collections open to submissions

NEW: Rare cancers

Guest Edited by Atif A. Ahmed and Bruna Samia Dalmasso 

NEW: Viral carcinogenesis

Guest Edited by Julian Naipauer

NEW: Altered DNA repair mechanisms in tumorigenesis

Guest Edited by Kiyohiro Ando, Pietro Di Fazio, and Zhihua Kang

NEW: Applications of ctDNA and liquid biopsies in precision oncology

Guest Edited by Claude Chelala and Pasquale Pisapia

Editors' Picks

New Content ItemIdentification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis

New Content ItemThe survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells

New Content ItemSynergistic lethality in chronic myeloid leukemia – targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment

Trending BMC Cancer Articles

Click here to view which Articles have been shared most in the last month!


Targeted Therapies for Cancer
Guest edited by Prof. Min Li and Dr. Yanis Boumber
Open for submissions

Microbiome and Cancer
Guest edited by Christopher Staley, Jacques Ravel, Sean Devlin
Open for submissions

Cross journal collection: Advances in CAR-T immunotherapy
Guest edited by Profs Marko Radic, Djordje Atanackovic and Tim Luetkens
Collection published: 30 June 2020

Cross journal collection: Precision Oncology
Collection published: 28 August 2019

Browse all BMC Cancer collection contributions

Aims and Scope

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials. Learn more about our scope here

Gastric Cancer Awareness Month

July - Sarcoma Awareness Month

Gastric Cancer Awareness Month runs for the whole of November. We hope you will enjoy reading the following study protocol recently published in BMC Cancer designed to prospectively identify 'oligo-metastatic disease', with the aim of proposing novel therapeutic approaches and monitoring strategies.

New Content ItemOligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

Become an Editorial Board Member

We are recruiting new Editorial Board Members.

Read More

New Content Item (1)

BMC Cancer is celebrating its 20th anniversary! 

Since launching in 2001, we've become established as the largest open access oncology journal in our field. We're proud of our history of making cancer research and methods available to all. We have been looking back at our achievements and highlighted some of the most influential research published in the journal over the past two decades. 

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • 2022 Citation Impact
    3.8 - 2-year Impact Factor
    4.3 - 5-year Impact Factor
    1.166 - SNIP (Source Normalized Impact per Paper)
    1.137 - SJR (SCImago Journal Rank)

    2022 Speed
    26 days submission to first editorial decision for all manuscripts (Median)
    148 days submission to accept (Median)

    2022 Usage 
    11,097 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal